Amanda Feilding and the Beckley Foundation are delighted to invite you to Psychedelic Science 2017. To celebrate the major advances being made in psychedelic research, the six-day gathering will bring together scientists, physicians, policy-makers and artists from around the world to share their latest discoveries and achievements.
As each year of this decade brings ever more science firsts for psychedelic research, there has never been a better time to unite practitioners and enthusiasts from across the world. Come and listen to Amanda Feilding, Rick Doblin, Stanislav Grof, Roland Griffiths, David Nutt, Anthony P. Bossis, James Fadiman and others at the multidisciplinary event from April 19-24 in Oakland, California.
With over 50 speakers, three full days of workshops, exhibitions and The Beckley Foundation Sunset cruise on the San Francisco Bay, Psychedelic Science 2017 will be a celebration of what has so far been achieved, and a comprehensive look at what lies ahead. Check out the full schedule, the Beckley Session speakers and our psychedelic research timeline.
Psychedelic Science 2017 will also feature a special screening of The Sunshine Makers, the new LSD documentary directed by Amanda Feilding’s son, Cosmo Feilding Mellen. The feature length film opened to fantastic reviews last week and has its nationwide release in the US today.
Here’s what the media are saying about it:
Los Angeles Times – LSD doc ‘The Sunshine Makers’ is a merry trip through 1960s counter-culture
The New York Times – Turning the world on, the LSD way, in ‘The Sunshine Makers’
The Village Voice – ‘The Sunshine Makers’ Offers a Breezy Trip Back in Time With the Kings of LSD
Two warriors for peace, a vat of chemicals, and an LSD cookbook. What could possibly go wrong?
Watch the trailer here
Early bird tickets for Psychedelic Science 2017 are on sale until Sunday 15 February.
We look forward to seeing you there.
Amanda Feilding and the Beckley Foundation team.
“The potential value of psychedelics has been airbrushed out of the scientific and medical cornucopia for decades. We are delighted to open the doors to research.”
– Amanda Feilding
Psilocybin for Depression
Type of publication